Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Acellular pertussis vaccines].

H Finger1, C H Wirsing von König

  • 1Institut für Hygiene, Städtische Krankenanstalten Krefeld.

Immunitat Und Infektion
|December 1, 1992
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Re: 'Association between pertactin-producing Bordetella pertussis and fulminant pertussis in infants: a multicentre study in France, 2008-2019' by Leroux et al.

Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases·2025
Same author

Pertussis vaccination in mixed markets: Recommendations from the Global Pertussis Initiative.

International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases·2020
Same author

Pertussis surveillance by small serosurveys of blood donors.

Epidemiology and infection·2018
Same author

Latent class analysis of diagnostic tests for adenovirus, Bordetella pertussis and influenza virus infections in German adults with longer lasting coughs.

Epidemiology and infection·2015
Same author

Analysis of Bordetella pertussis clinical isolates circulating in European countries during the period 1998-2012.

European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology·2014
Same author

Investigations into the emergence of pertactin-deficient Bordetella pertussis isolates in six European countries, 1996 to 2012.

Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin·2014
Same journal

[Cat scratch disease caused by Bartonella henselae].

Immunitat und Infektion·1995
Same journal

[Gas gangrene as a manifestation of endogenous Clostridium septicum infection].

Immunitat und Infektion·1995
Same journal

[Actinomycetes canaliculitis--case reports].

Immunitat und Infektion·1995
Same journal

[Leprosy--current aspects of a disease from biblical times].

Immunitat und Infektion·1995
Same journal

[Rational use of antimycotics against yeast infections].

Immunitat und Infektion·1995
Same journal

[Antimicrobial oligopeptides--an important factor in non-specific defense against infection].

Immunitat und Infektion·1995
See all related articles

New acellular pertussis vaccines offer fewer side effects than whole-cell vaccines. Ongoing trials are confirming their protective efficacy is equivalent to older pertussis vaccines.

Area of Science:

  • Immunology
  • Vaccinology
  • Public Health

Background:

  • Whole-cell pertussis vaccines are effective but cause frequent side effects.
  • Research has focused on developing less reactogenic acellular pertussis vaccines.
  • Several acellular pertussis vaccines with varying compositions have been created.

Purpose of the Study:

  • To evaluate the safety and efficacy of newly developed acellular pertussis vaccines.
  • To compare the reactogenicity of acellular vaccines against conventional whole-cell pertussis vaccines.
  • To assess the protective efficacy of acellular pertussis vaccines through epidemiological data and ongoing field trials.

Main Methods:

  • Development and compositional analysis of several acellular pertussis vaccines.

Related Experiment Videos

  • Comparative assessment of local and systemic side effects between acellular and whole-cell vaccines.
  • Analysis of epidemiological data to infer vaccine efficacy.
  • Conducting controlled field trials to directly compare protective efficacy.

    • Main Results:

    • Acellular pertussis vaccines demonstrated significantly reduced local and systemic side effects compared to whole-cell vaccines.
    • Epidemiological evidence supports the efficacy of these acellular vaccines.
    • Controlled field trials are currently underway to establish efficacy equivalence.

    Conclusions:

    • Acellular pertussis vaccines represent a safer alternative to whole-cell vaccines due to reduced reactogenicity.
    • Current evidence suggests acellular pertussis vaccines are effective.
    • Further data from ongoing controlled field trials are necessary to confirm equivalent protective efficacy to whole-cell vaccines.